Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington's Disease Huntington's Disease

Status unconfirmed

Conditions studied: Huntington Disease

In brief

The principal means of measuring motor impairment in Huntington disease (HD) is the Unified Huntington's Disease Rating Scale (UHDRS) total motor score, which is subjective, categorical, requires significant training to administer correctly, and only captures impairments in clinic. In this Direct to Phase II SBIR we will develop a wearable sensor system for objective, sensitive, and continuous assessment of Huntington's chorea during activities of daily living. The developed technology could be used clinically to detect changes in motor function in response to medications, or could be used scientifically to expedite and reduce the cost of early stage pharmaceutical clinical trials.

Key facts

Study ID

NCT03599076

Run by

BioSensics

People needed

50

Starts

2018-09-25

Expected to finish

2019-12-01

Last updated by the study team

2019-01-24

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• CAG expansion ≥ 36

You may not qualify if…

• N/A

Where it is running

• University of Rochester — Rochester, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.